Morten Blaabjerg

Medicine & Life Sciences

1. Traumatic Brain Injury 100%
2. Hashimoto's encephalitis 84%
3. Encephalitis 46%
4. Parkinson Disease 43%
5. Metabotropic Glutamate Receptors 43%
6. Cohort Studies 40%
7. Cerebrospinal Fluid 39%
8. Brain 38%
9. Antibodies 33%
10. Migraine with Aura 32%
11. N-Methyl-D-Aspartate Receptors 29%
12. Neural Stem Cells 29%
13. Neurogenesis 28%
14. Levodopa 27%
15. Dyskinesias 24%
16. Glioma 24%
17. Chronic Inflammatory Demyelinating Polyradiculoneuropathy 23%
18. Propidium 22%
19. Amyotrophic Lateral Sclerosis 22%
20. Multiple System Atrophy 21%
21. Excitatory Amino Acid Antagonists 21%
22. Denmark 19%
23. Steroids 19%
24. Leucine 19%
25. Therapeutics 18%
26. Intracranial Pressure 18%
27. Twins 18%
28. Excitatory Amino Acid Agonists 17%
29. Seizures 17%
30. N-Methylaspartate 17%
31. Inflammation 17%
32. Post-Traumatic Stress Disorders 16%
33. 3,4-dihydroxyphenylglycol 15%
34. Multiple Sclerosis 15%
35. White Matter 15%
36. Neurons 14%
37. 2-amino-3-phosphonopropionic acid 14%
38. Wounds and Injuries 14%
39. Lateral Ventricles 14%
40. Pathology 14%
41. Survival 13%
42. Biomarkers 13%
43. Observational Studies 13%
44. Neurodegenerative Diseases 13%
45. metabotropic glutamate receptor type 1 13%
46. 1-amino-1,3-dicarboxycyclopentane 13%
47. Pilocarpine 13%
48. cyclic citrullinated peptide 12%
49. Stiff-Person Syndrome 12%
50. metabotropic glutamate receptor 2 12%